Public Data
12 samples
Bulk mRNA Seq CAR.CCR7 vs. CAR
Accession: ERP145839
Published: 2023
primary cells
gene, gene: overexpression
normal
Public Data
3 samples
BRBseq performed on 786-O cells treated with 2 inhibitors of protein kinase CK2, CX4945 and AB668
Accession: ERP145812
Published: 2023
cell line
bioactive entity
kidney
renal cell carcinoma
Public Data
6 samples
Analysis of ARID3A regulated genes in K562 cells
Accession: ERP144939
Published: 2023
cell line
gene, gene: shrna
bone marrow
chronic myelogenous leukemia, BCR-ABL1 positive
Public Data
10 samples
RNA-seq of hESC-derived cardiac cells (H9 cell line) on day 8, comparing control vs PD0325901.
Accession: ERP144654
Published: 2023
cell line, organoid
bioactive entity
inner cell mass
normal
Public Data
10 samples
RNA-seq of H9 cell line during differentiation from na?ve extraembryonic endoderm to extraembryonic mesoderm.
Accession: ERP144055
Published: 2023
cell line
inner cell mass
normal
Public Data
20 samples
Sensitivity of gastric cancer cells to all-trans retinoic acid, a new agent in the personalized treatment of this heterogeneous tumor: definition of a predictive gene-expression model that may be used for the selection of patients who may benefit from retinoid-based treatments (Xenografts)
Accession: ERP142827
Published: 2023
xenograft
bioactive entity
stomach
gastric carcinoma, gastric tubular adenocarcinoma
Public Data
26 samples
Sensitivity of gastric cancer cells to all-trans retinoic acid, a new agent in the personalized treatment of this heterogeneous tumor: definition of a predictive gene-expression model that may be used for the selection of patients who may benefit from retinoid-based treatments
Accession: ERP142797
Published: 2023
cell line
bioactive entity
stomach
gastric cancer
Public Data
96 samples
Sensitivity of gastric cancer cells to all-trans retinoic acid, a new agent in the personalized treatment of this heterogeneous tumor: definition of a predictive gene-expression model that may be used for the selection of patients who may benefit from retinoid-based treatments (Cell Lines)
Accession: ERP142778
Published: 2023
cell line
bioactive entity
stomach
gastric adenocarcinoma, gastric carcinoma, ...
Public Data
23 samples
Development and characterisation of an in vitro human muscle self-repair model
Accession: ERP141482
Published: 2023
primary cells
other
skeletal muscle tissue
normal
Public Data
15 samples
RNA-seq of the U2OS cell line (Human Bone Osteosarcoma Epithelial Cells) treated with ZMYM2, TRIM28 or ADNP knock down against the control conditions.
Accession: ERP141652
Published: 2023
cell line
gene, gene: sirna
tibia
osteosarcoma
Public Data
18 samples
RNAseq of HUVECs transfected with siRNA targeting Neuropilin 1 (NRP1) (si-NRP1) or a control non-targeting sequence (si-control) and exposed to unidirectional shear stress (20dyns/cm2), oscillatory flow (5dyn/cm2) or kept in absence of flow
Accession: ERP141092
Published: 2023
cell line
gene, gene: sirna, ...
umbilical vein
normal
Public Data
12 samples
MAT2A promotes reprogramming of the androgen response pathway in association with ERG and EZH2
Accession: ERP140142
Published: 2023
cell line
gene, gene: overexpression
prostate gland
normal
Public Data
8 samples
RNA-seq of human hepatic arteries in a study of primary sclerosing cholangitis
Accession: ERP139411
Published: 2023
primary tissue
hepatic artery
normal, primary sclerosing cholangitis
Public Data
12 samples
Kaposi's Sarcoma-associated Herpesvirus Viral Protein Kinase Augments Cell Survival
Accession: SRP457650
Published: 2023 in Cell Death Dis
cell line
other
umbilical vein
Public Data
9 samples
RNA-seq of 293T cells expressing different RUNX1 splice isoforms
Accession: ERP138633
Published: 2023
cell line
gene, gene: overexpression
kidney
normal